Therefore, we hypothesise that cancer pain patients carrying the rs6853 SNP are at lower risk of developing cognitive dysfunction due to reduced MyD88 activity driving the neuroimmune signalling associated with cognitive impairment. Here, MYD88 is linked to cancer.